文献速递多重用药老年综合评估

减少不适当慢性用药干预措施结局指标:叙述性综述

Outcome Measures for Interventions to Reduce Inappropriate Chronic Drugs: A Narrative Review.
PubMed 文献 · J Am Geriatr Soc · 2020-08-11

该叙述性综述检索Ovid/MEDLINE 2010至2019年成人慢性药物减停干预研究,提取并分类结局指标。93项研究中90项采用适当处方指标(如停药或减量),患者报告体验、偏好和结局及非预期后果指标使用较少,研究间指标数量和类型差异大。综述建议未来研究纳入患者和提供者为中心的指标及非预期后果指标。

要点

  • 减停干预研究多用停药或减量等处方指标,患者报告结局使用不足。
  • 患者报告体验、偏好和结局及提供者报告体验、医患互动指标使用率低。
  • 研究间结局指标类型和数量差异大,从1到20种不等。

核心结论

  • 为确保减停的启动、成功和长期可持续性,干预研究应使用临床相关的以患者和提供者为中心的结局指标。
  • 该综述对减停研究结局指标的分类汇总有助于未来研究实施重要指标类型。

研究设计与样本

  • 叙述性综述,检索Ovid/MEDLINE,纳入2010至2019年发表的成人慢性药物减停干预研究,提取研究特征、干预组成和结局指标并按框架分类。

主要发现

  • 患者报告体验、偏好和结局分别见于12项(13%)、2项(2%)和25项(27%)研究。
  • 提供者报告体验见于11项(12%)研究,患者-提供者互动见于4项(4%)研究。
  • 非预期后果指标见于24项(26%)研究。
  • 各研究评估的指标类型和数量不一,从1到20种不同指标不等。

关键数值与推荐

  • 最常用指标为适当处方指标(停药或减量),见于90/93项研究。
  • 患者报告体验、偏好和结局分别见于12/93、2/93和25/93项研究。
  • 提供者报告体验见于11/93项研究,患者-提供者互动见于4/93项研究。
  • 非预期后果指标见于24/93项研究。

临床怎么用

  • 设计减停干预研究时,除处方指标外应纳入患者报告体验、偏好和结局指标。
  • 应评估非预期后果指标以全面评价减停干预的成功与可持续性。
  • 可参考该综述的指标分类框架选择临床相关的患者和提供者为中心指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inappropriate prescribing is a highly important problem, given the growing aging multimorbid population with associated polypharmacy. An increasing number of studies have recently developed and tested interventions to withdraw inappropriate drugs, a process called deprescribing. However, we still lack complete information on the types and prevalence of measures used to assess the success of such interventions. OBJECTIVE: To categorize and synthesize the full spectrum of measures used in intervention studies focused on reducing inappropriate prescribing of chronic drugs in adults, to standardize measurements in future studies and help researchers design studies inclusive of the important measure types. DESIGN: We searched Ovid/MEDLINE to identify intervention studies focused on deprescribing chronic drugs in adults, published between 2010 and 2019. MEASUREMENTS: We extracted data on study characteristics, intervention components, and outcome measures. We categorized and synthesized the measures using a comprehensive and systematic framework, separating measures of intended and unintended consequences. RESULTS: Most (90/93) studies used measures of appropriate prescribing, such as drug cessation or dose reduction. The following measures were used infrequently across studies: patient-reported experience, preferences, and outcome (12 (13%), 2 (2%), and 25 (27%) studies, respectively); provider-reported experience (11 (12%) studies); patient-provider interaction (4 (4%) studies); and measures of unintended consequences (24 (26%) studies). Studies varied in the type and number of measures assessed, ranging from 1 to 20 different measures by study. CONCLUSION: To ensure initiation, success, and long-term sustainability of deprescribing, it is important to assess the success of intervention studies using clinically relevant patient- and provider-centered measures. This categorized synthesis of outcome measures used in deprescribing studies may facilitate implementation of important measure types (e.g., patient-reported measures and measures of unintended consequences) in future studies. J Am Geriatr Soc 68:2390-2398, 2020.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Aubert CE, Kerr EA, Maratt JK, et al. Outcome Measures for Interventions to Reduce Inappropriate Chronic Drugs: A Narrative Review. J Am Geriatr Soc. 2020. PMID: 32780416. doi:10.1111/jgs.16697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。